Improving Outcomes in Patients With Kidney Disease Due to Diabetes

NCT00381134 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

92

Enrollment

NIH

Sponsor class

Conditions

Diabetes
Kidney Disease
Hypertension

Interventions

DRUG: losartan 100 mg orally once daily
DRUG: spironolactone 25 mg orally once daily
DRUG: placebo once orally once daily

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)